Vimarsana
Biggest News Aggregation in the World

Page 30 - Stem Cell Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stem Cell Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stem Cell Therapy Today - Breaking & Trending Today

IIT Guwahati 2023: A Year of Innovations, Collaborations, and Academic Excellence - Vimarsana News

IIT Guwahati 2023: A Year of Innovations, Collaborations, and Academic Excellence

GUWAHATI : In 2023, Indian Institute of Technology Guwahati achieved milestones in research, infrastructure, placements, and collaborations, hosting the G20-Y20 Inception Meet, developing 'Smart Drones,' and establishing the Assam Advanced Healthcare

EU Conditional Approval: Gene Editor to Treat Blood Diseases - Vimarsana News

EU Conditional Approval: Gene Editor to Treat Blood Diseases

The single-dose therapy involves treating and editing patient stem cells ex vivo, then reinfusing them.

GVHD Raises Vitiligo Risk in Transplant Recipients - Vimarsana News

GVHD Raises Vitiligo Risk in Transplant Recipients

"The findings suggest that early detection and management of vitiligo lesions can be improved by estimating the likelihood of its development in transplant recipients..."

This Frontline Therapy Is Better in Multiple Myeloma: Study - Vimarsana News

This Frontline Therapy Is Better in Multiple Myeloma: Study

A study directly comparing real-world outcomes suggests patients with transplant-ineligible multiple myeloma do better with frontline triple therapy with daratumumab vs bortezomib.

No Benefit to Salvage Transplant in R/R Multiple Myeloma - Vimarsana News

No Benefit to Salvage Transplant in R/R Multiple Myeloma

Long-term follow-up shows no progression-free or overall survival advantage among patients who received salvage transplant vs continuous lenalidomide plus dexamethasone.